Christy Chuang‐Stein

Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)

Scott Evans, Daniel B. Rubin, Dean Follmann et al. · Clinical Infectious Diseases · 2015 · 323 citations · Full text

Patient Selection, Antibiotic Resistance, Drug Resistance +22

Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group

Paul Gallo, Christy Chuang‐Stein, Vladimir Dragalin et al. · Journal of Biopharmaceutical Statistics · 2006 · 305 citations

White Paper, Optimal Experimental Design, Pharmacotherapy +18

Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia

Earle Bain, Laura Shafner, David P. Walling et al. · JMIR mhealth and uhealth · 2017 · 160 citations · Full text

Sample size and the probability of a successful trial

Christy Chuang‐Stein · Pharmaceutical Statistics · 2006 · 125 citations

Reliability, Engineering, Patient Recruitment +11

Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America

Walter Offen, Christy Chuang‐Stein, Alex Dmitrienko et al. · Drug Information Journal · 2007 · 122 citations · Full text

Medicine, Clinical Endpoint, Outcomes Research +8